Current Report Filing (8-k)
April 02 2014 - 4:41PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
April 2, 2014
Date
of Report (date of earliest event reported)
TransEnterix,
Inc.
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
0-19437 |
|
11-2962080 |
(State or other jurisdiction of
incorporation or organization) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification Number) |
635 Davis Drive, Suite 300
Morrisville, North Carolina
(Address of principal executive offices)
919-765-8400
(Registrants telephone number, including area code)
Not Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events.
TransEnterix, Inc. (the Company) updated its Company presentation (the Presentation) on April 2, 2014. A copy of the Presentation
is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The Presentation will be used during investor meetings beginning on April 2, 2014.
Item 9.01 Financial Statements and Exhibits.
|
|
|
Exhibit No. |
|
Description |
99.1 |
|
TransEnterix, Inc. Company presentation dated April 2, 2014 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
TRANSENTERIX, INC. |
|
|
|
Date: April 2, 2014 |
|
|
|
/s/ Joseph P. Slattery |
|
|
|
|
Joseph P. Slattery |
|
|
|
|
Executive Vice President and Chief
Financial Officer |
Safeguard Scientifics (QX) (USOTC:SFES)
Historical Stock Chart
From Nov 2024 to Dec 2024
Safeguard Scientifics (QX) (USOTC:SFES)
Historical Stock Chart
From Dec 2023 to Dec 2024